SCHEMBL31335779

SCHEMBL31335779

COCOc1cc(OCOC)c(C(=O)N2Cc3cccc(NC(=O)/C=C/CN4CC(F)(F)C4)c3C2)cc1C

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 3/20 0.35
EGFR P00533 6/20 0.33
TRAP1 Q12931 6/20 0.33
HSP90B1 P14625 4/20 0.33
BTK Q06187 1/20 0.31
ERBB2 P04626 2/20 0.31
JAK3 P52333 1/20 0.30
ERBB4 Q15303 1/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
POLB P06746 1/20 0.30
CYP3A4 P08684 1/20 0.30
GAA P10253 1/20 0.30
CYP2C9 P11712 1/20 0.30
RAB9A P51151 1/20 0.30
CCNK O75909 1/20 0.30
CDK12 Q9NYV4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31335739 0.94 PDCD1 (0.34) SLC6A9EGFRTRAP1HSP90B1BTK
SCHEMBL31335540 0.84 TRAP1 (0.41) TRAP1HSP90B1
SCHEMBL31335611 0.78 TRAP1 (0.39) EGFRTRAP1HSP90B1BTK
SCHEMBL31335831 0.74 TRAP1 (0.42) SLC6A9TRAP1HSP90B1
SCHEMBL31335521 0.73 TRAP1 (0.43) EGFRTRAP1HSP90B1BTK
SCHEMBL31335595 0.72 TRAP1 (0.44) TRAP1HSP90B1
SCHEMBL31335877 0.71 SLC6A9 (0.40) SLC6A9TRAP1HSP90B1POLBGAA
SCHEMBL31335516 0.71 BTK (0.44) EGFRTRAP1HSP90B1BTKERBB2
SCHEMBL31335842 0.68 TRAP1 (0.44) TRAP1HSP90B1BTK
SCHEMBL31336029 0.67 HSP90B1 (0.44) EGFRTRAP1HSP90B1BTKNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 WO disclosed